Skip to content

Effect of herbal supplement based on traditional medicine versus placebo with weight loss diet on some biochemical parameters & Anthropometric indices in obese subjects

The study randomized clinical trial for comparing the effect of herbal supplement based on traditional medicine versus placebo with weight loss diet on some biochemical parameters & Anthropometric indices in obese subjects

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201307272017N17
Enrollment
68
Registered
2014-06-04
Start date
2014-05-31
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity. Obesity due to excess calories

Interventions

3 grams powdered corn starch as 3 capsuls per day for 60 day
Intervention 1: 3 grams powdered dry(Origanum vulgare,Carum carvi,Trachyspermum copticum,Ruta Graveolen)as 3 capsuls per day for two months. Intervention 2: 3 grams powdered corn starch as 3 capsuls p
Treatment - Drugs
Placebo
3 grams powdered dry(Origanum vulgare,Carum carvi,Trachyspermum copticum,Ruta Graveolen)as 3 capsuls per day for two months

Sponsors

Nutrition Research Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Having BMI more than or equal 30; Age between 20 to 50 years old; Inform consent signed by the patient; Those who can over the next two months two times refer for take drugs and laboratory examination ; Waist circumference > 102 cm (men) or > 88 cm (women). Exclusion Criteria: Inform consent not signed by the patient; Those who can not over the next two months two times refer for take drugs and laboratory examination; Heavy Smoking(More than twenty cigarettes per daily); Diabetes mellitus; Patients with coronary heart vascular disease ;Patients with proven malignancy; Asthma; Chronic cough; Chronic lung inflammatory and bowel disease; Fever of unknown origin; Patients with a history of chronic kidney and liver disease(Exception fatty liver and not including obesity, allergies, skin problems, or occasional GERD or IBS symptoms); Obesity due to endocrine (hypothyroidism, uncontrolled disease) disease.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Anthropometric measurements. Timepoint: 2 Times during the study: at the beginning and end of intervention. Method of measurement: Anthropometric measurements including weight using calibrated Seca scale with a precision of 0/1 kg and a minimum of clothes in the morning, height, waist and hip circumference using a tape measure with an accuracy of 0.1 cm, and Bio Mass Index and waist-hip ratio was calculated.;Body composition. Timepoint: 2 Times during the study: at the beginning and end of each intervention month. Method of measurement: Measurement of body composition, including fat mass, fat free mass and total body water determination using Bioelectric Impedance Analyzer ( BIA).;Energy and nutrient intake. Timepoint: 3 Times; at first, midst and the end of intervention. Method of measurement: 3 Dayes food record was used and analyzed with Nutritionist 4 software.

Secondary

MeasureTime frame
Fasting srum lipid profile (Low Density Lipoprotein,High Density Lipoprotein,total cholesterol,Three Glycerid). Timepoint: Before and after intervention. Method of measurement: Enzymatic method for total cholesterol, triglyceride and High Density Lipoprotein and Freidwald’s formula forLow Density Lipoprotein.c.;Hepatic Enzyms. Timepoint: Before and after intervention. Method of measurement: kits.;Dertemining of Uric acid, Cratinin, Bilirubin. Timepoint: Before and after intervention. Method of measurement: kits.;Serum inflammatory values (Inter lukine-6, Tumor necrosis factors-a, High-sensitivity C-reactive Protein). Timepoint: Before and after intervention. Method of measurement: High-sensitivity C-reactive Protein assess with Immunotorbidometric method and Inter lukine-6, Tumor necrosis factors-a with Eliza method.;Serum levels of leptin, Grelin. Timepoint: Befor and after intervention. Method of measurement: By Laboratory ELISA Kits.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactEinollah valizadeh

Tabriz University of Medical Sciences

evalizade@yahoo.com+98 41 1335 2295

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026